Results 101 to 110 of about 2,893,372 (329)

Diagnosis and Treatment of Primary Tracheobronchial Tumors

open access: yesCancer Medicine, Volume 14, Issue 9, May 2025.
ABSTRACT Background Primary tracheobronchial tumors (PTBTs) are rare but life‐threatening, accounting for approximately 0.2% of all respiratory neoplasms. Owing to their nonspecific clinical symptoms, PTBTs are often initially misdiagnosed as bronchial asthma or bronchitis in the early stages.
Chen Shu   +9 more
wiley   +1 more source

Partial abdominal evisceration and intestinal autotransplantation to resect a mesenteric carcinoid tumor

open access: yesWorld Journal of Surgical Oncology, 2011
Background Midgut carcinoids are neuroendocrine tumors that commonly metastasize to the intestinal mesentery, where they predispose to intestinal obstruction, ischemia and/or congestion.
Cosimi A Benedict   +4 more
doaj   +1 more source

Primary renal well‐differentiated neuroendocrine tumors with lymph node metastasis: A case report and literature review

open access: yesIJU Case Reports, Volume 8, Issue 3, Page 202-205, May 2025.
Introduction Well‐differentiated neuroendocrine tumors of the kidney are rare and generally less aggressive than renal cell carcinoma, although metastasis is still present at the time of diagnosis. Surgical resection remains the preferred treatment, even in cases with lymph node metastases.
Huy‐Hoang Nguyen   +3 more
wiley   +1 more source

Primary carcinoid tumors of the liver

open access: yesWorld Journal of Surgical Oncology, 2008
Background Primary carcinoid tumors of the liver are uncommon and rarely symptomatic. The diagnosis of primary hepatic etiology requires rigorous workup and continued surveillance to exclude a missed primary.
Olichney John   +4 more
doaj   +1 more source

Struma Ovarii Associated with Pseudo- Meigs’Syndrome [PDF]

open access: yes, 2012
Struma ovarii is a specialized ovarian teratoma composed predominantly of mature thyroid tissue. It is associated with pleural effusion and ascites (Pseudo-Meigs’ syndrome) in 5% of cases.
Gangane, NM, Gulhane, SR, Sinha, RT
core   +1 more source

Antifungal Resistance Among Candida Species: Diagnostic and Clinical Challenges in Specialized Cancer Care Hospital of Lahore

open access: yesJournal of Clinical Laboratory Analysis, Volume 39, Issue 9, May 2025.
Consumption of antifungals showed a declining trend, with the highest consumption of oral voriconazole (mean DOT/1000 pt. days 18653.49) and oral fluconazole (mean DOT/1000 pt. days 15258.14). Candida albicans was the most isolated pathogen 768 (53.60%) and among all Candida species, major resistance was found in Candida tropicalis 58 (4.05%).
Zunaira Akbar   +6 more
wiley   +1 more source

Primary carcinoid tumors at atypical sites: surgery is mandatory and size determines survival—an Egyptian study

open access: yesBulletin of the National Research Centre, 2019
Background Carcinoids at atypical sites are rare and mostly asymptomatic. In the majority, they show normal levels of serotonin and its metabolites in plasma and urine, resulting in a relatively late diagnosis and hence guarded prognosis.
Karim G. Moustafa, Gamal M. Saied
doaj   +1 more source

Carcinoid Heart Disease on Computed Tomography

open access: yesJournal of the Belgian Society of Radiology, 2020
Teaching Point: Carcinoid tumors can release hormones responsible of cardiac valves fibrosis known as carcinoid heart disease.
Jean-Philippe Hardy, Benoît Ghaye
doaj   +1 more source

Cancer and nonextensive statistics [PDF]

open access: yes, 2006
We propose a new model of cancer growth based on nonextensive entropy. The evolution equation depends on the nonextensive parameter q. The exponential, the logistic, and the Gompertz growth laws are particular cases of the generalized model. Experimental data of different tumors have been shown to correspond to all these tumor-growth laws.
arxiv   +1 more source

Meta-analysis of stomatitis in clinical studies of everolimus: incidence and relationship with efficacy. [PDF]

open access: yes, 2016
BackgroundEverolimus, an oral mammalian target of rapamycin (mTOR) inhibitor, is used to treat solid tumors and tuberous sclerosis complex (TSC). Stomatitis, an inflammation of the mucous membranes of the mouth, is a common adverse event associated with ...
Anak, O   +10 more
core  

Home - About - Disclaimer - Privacy